These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 33414901)

  • 1. Patient perspectives on living with severe asthma in Denmark and Sweden.
    Papapostolou G; Tunsäter A; Binnmyr J; Telg G; Roslind K
    Eur Clin Respir J; 2020 Dec; 8(1):1856024. PubMed ID: 33414901
    [No Abstract]   [Full Text] [Related]  

  • 2. Health-Related Quality of Life and Productivity Among US Patients with Severe Asthma.
    Soong W; Chipps BE; O'Quinn S; Trevor J; Carr WW; Belton L; Trudo F; Ambrose CS
    J Asthma Allergy; 2021; 14():713-725. PubMed ID: 34211280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qualitative evaluation of the St George's Respiratory Questionnaire in patients with severe asthma.
    Nelsen LM; Kimel M; Murray LT; Ortega H; Cockle SM; Yancey SW; Brusselle G; Albers FC; Jones PW
    Respir Med; 2017 May; 126():32-38. PubMed ID: 28427547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the psychometric properties of the St George's Respiratory Questionnaire in patients with severe asthma.
    Nelsen LM; Vernon M; Ortega H; Cockle SM; Yancey SW; Brusselle G; Albers FC; Jones PW
    Respir Med; 2017 Jul; 128():42-49. PubMed ID: 28610668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial.
    Harrison TW; Chanez P; Menzella F; Canonica GW; Louis R; Cosio BG; Lugogo NL; Mohan A; Burden A; McDermott L; Garcia Gil E; Zangrilli JG;
    Lancet Respir Med; 2021 Mar; 9(3):260-274. PubMed ID: 33357499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.
    Rees S; Williams A
    JBI Libr Syst Rev; 2009; 7(13):492-582. PubMed ID: 27819974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of exacerbations on St George's Respiratory Questionnaire score in patients with severe asthma: post hoc analyses of two clinical trials and an observational study.
    Nelsen LM; Cockle SM; Gunsoy NB; Jones P; Albers FC; Bradford ES; Mullerova H
    J Asthma; 2020 Sep; 57(9):1006-1016. PubMed ID: 31251094
    [No Abstract]   [Full Text] [Related]  

  • 8. Extrapulmonary associations of health status in severe asthma and bronchiectasis: Comorbidities and functional outcomes.
    Cordova-Rivera L; Gibson PG; Gardiner PA; Hiles SA; McDonald VM
    Respir Med; 2019; 154():93-101. PubMed ID: 31229944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weight loss interventions for chronic asthma.
    Adeniyi FB; Young T
    Cochrane Database Syst Rev; 2012 Jul; (7):CD009339. PubMed ID: 22786526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of asthma education on asthma knowledge and health-related quality of life in Taiwanese asthma patients.
    Wang KY; Wu CP; Ku CH; Chang NW; Lee YH; Lai HR
    J Nurs Res; 2010 Jun; 18(2):126-35. PubMed ID: 20592658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric assessment of the Chinese language version of the St. George's Respiratory Questionnaire in Taiwanese patients with bronchial asthma.
    Wang KY; Chiang CH; Maa SH; Shau WY; Tarn YH
    J Formos Med Assoc; 2001 Jul; 100(7):455-60. PubMed ID: 11579610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability and validity of the St George's Respiratory Questionnaire for asthma.
    Bae YJ; Kim YS; Park CS; Lee YS; Chang YS; Cho YS; Jang AS; Cho SH; Choi BW; Kim SG; Moon HB; Kim TB;
    Int J Tuberc Lung Dis; 2011 Jul; 15(7):966-71. PubMed ID: 21682973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial.
    Chupp GL; Bradford ES; Albers FC; Bratton DJ; Wang-Jairaj J; Nelsen LM; Trevor JL; Magnan A; Ten Brinke A
    Lancet Respir Med; 2017 May; 5(5):390-400. PubMed ID: 28395936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the St George's respiratory questionnaire and risks factors affecting the quality of life of Lebanese COPD and asthma patients.
    Akiki Z; Hallit S; Layoun N; Cherfane M; Sacre H; Waked M; Salameh P
    J Asthma; 2019 Nov; 56(11):1212-1221. PubMed ID: 30359153
    [No Abstract]   [Full Text] [Related]  

  • 15. A randomized, controlled study to evaluate the role of an in-home asthma disease management program provided by respiratory therapists in improving outcomes and reducing the cost of care.
    Shelledy DC; Legrand TS; Gardner DD; Peters JI
    J Asthma; 2009 Mar; 46(2):194-201. PubMed ID: 19253130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient Perceptions of Living with Severe Asthma: Challenges to Effective Management.
    Apps LD; Chantrell S; Majd S; Eglinton E; Singh SJ; Murphy AC; Bradding P; Green RH; Hudson N; Evans RA
    J Allergy Clin Immunol Pract; 2019; 7(8):2613-2621.e1. PubMed ID: 31178414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial.
    Lee LA; Bailes Z; Barnes N; Boulet LP; Edwards D; Fowler A; Hanania NA; Kerstjens HAM; Kerwin E; Nathan R; Oppenheimer J; Papi A; Pascoe S; Brusselle G; Peachey G; Sule N; Tabberer M; Pavord ID
    Lancet Respir Med; 2021 Jan; 9(1):69-84. PubMed ID: 32918892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mepolizumab versus placebo for asthma.
    Powell C; Milan SJ; Dwan K; Bax L; Walters N
    Cochrane Database Syst Rev; 2015 Jul; (7):CD010834. PubMed ID: 26214266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term health-related quality-of-life and symptom response profiles with arformoterol in COPD: results from a 52-week trial.
    Donohue JF; Bollu VK; Stull DE; Nelson LM; Williams VS; Stensland MD; Hanania NA
    Int J Chron Obstruct Pulmon Dis; 2018; 13():499-508. PubMed ID: 29440887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Life Impact and Treatment Preferences of Individuals with Asthma and Chronic Obstructive Pulmonary Disease: Results from Qualitative Interviews and Focus Groups.
    Svedsater H; Roberts J; Patel C; Macey J; Hilton E; Bradshaw L
    Adv Ther; 2017 Jun; 34(6):1466-1481. PubMed ID: 28536998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.